{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:53:59Z","timestamp":1784674439713,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.clgc.2016.05.017","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T21:03:00Z","timestamp":1464469380000},"page":"256-262.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-4467","authenticated-orcid":false,"given":"Daniel P.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padraic","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Al Hussein Al Awamlh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Alain","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel P.","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Scherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.05.017_bib1","first-page":"11","article-title":"Cancer Statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2016.05.017_bib2","doi-asserted-by":"crossref","first-page":"52.e1","DOI":"10.1016\/j.urolonc.2013.08.007","article-title":"Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients","volume":"32","author":"Mitra","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2016.05.017_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.urology.2013.10.060","article-title":"Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis","volume":"83","author":"Messer","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.017_bib4","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/jnci\/82.20.1636","article-title":"Unexplained exces risk of bladder cancer in men","volume":"82","author":"Hartge","year":"1990","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2016.05.017_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1464-410X.2009.09076.x","article-title":"The effect of age and gender on bladder cancer: a critical review of the literature","volume":"105","author":"Shariat","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2016.05.017_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000474484","article-title":"Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats","volume":"31","author":"Imada","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2016.05.017_bib7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/jnci\/djk113","article-title":"Promotion of bladder cancer development and progression by androgen receptor signals","volume":"99","author":"Miyamoto","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clgc.2016.05.017_bib8","first-page":"276","article-title":"Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer","volume":"188","author":"Shiota","year":"2012","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clgc.2016.05.017_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.urology.2004.03.025","article-title":"Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer","volume":"64","author":"Boorjian","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.017_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.urolonc.2009.01.033","article-title":"Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression","volume":"29","author":"Tuygun","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2016.05.017_bib11","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","article-title":"Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder","volume":"109","author":"Miyamoto","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2016.05.017_bib12","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/cncr.21945","article-title":"Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue","volume":"106","author":"Shen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2016.05.017_bib13","doi-asserted-by":"crossref","first-page":"32510","DOI":"10.1074\/jbc.M202852200","article-title":"Raloxifene, a mixed estrogen agonist\/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells","volume":"277","author":"Kim","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clgc.2016.05.017_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/carcin\/bgt348","article-title":"Suppression of ER\u03b2 signaling via ER\u03b2 knockout or antagonist protects against bladder cancer development","volume":"35","author":"Hsu","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clgc.2016.05.017_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000324262","article-title":"Expression of ER\u03b2 and its co-regulators p300 and NCoR in human transitional cell bladder cancer","volume":"87","author":"Kontos","year":"2011","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2016.05.017_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/or.2013.2416","article-title":"Estrogen receptor-\u03b2 expression and pharmacological targeting in bladder cancer","volume":"30","author":"Kauffman","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clgc.2016.05.017_bib17","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis\u2014some new perspectives","volume":"142","author":"Simpson","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.clgc.2016.05.017_bib18","series-title":"Urinary bladder. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual","first-page":"335","year":"2002"},{"key":"10.1016\/j.clgc.2016.05.017_bib19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2016.05.017_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jneuroim.2004.10.021","article-title":"Gene expression profiling in chronic inflammatory demyelinating polyneuropathy","volume":"159","author":"Renaud","year":"2005","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.clgc.2016.05.017_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1464-410X.2010.09834.x","article-title":"Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study","volume":"108","author":"Mir","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2016.05.017_bib22","first-page":"2698","article-title":"Sex steroid receptors in male human bladder: expression and biological function","volume":"7","author":"Chavalmane","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.clgc.2016.05.017_bib23","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1096\/fj.12-219048","article-title":"Seminal vesicles and urinary bladder as sites of aromatization of androgens in men, evidenced by a CYP19A1-driven luciferase reporter mouse and human tissue specimens","volume":"27","author":"Strauss","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.clgc.2016.05.017_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12672-012-0123-9","article-title":"Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation","volume":"4","author":"Hoffman","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/j.clgc.2016.05.017_bib25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.urology.2007.02.041","article-title":"Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma","volume":"69","author":"Sonpavde","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.017_bib26","first-page":"1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clgc.2016.05.017_bib27","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/endo.137.12.8940410","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.clgc.2016.05.017_bib28","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.urology.2005.06.079","article-title":"Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome","volume":"66","author":"Barocas","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2016.05.017_bib29","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/carcin\/20.10.1963","article-title":"Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides","volume":"20","author":"Ciotti","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clgc.2016.05.017_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mc.21833","article-title":"Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis","volume":"52","author":"Izumi","year":"2013","journal-title":"Mol Carcinog"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316301434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316301434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:28:11Z","timestamp":1761564491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767316301434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1558767316301434"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.05.017","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Aromatase With Bladder Cancer Stage and Long-Term Survival: New Insights Into the Hormonal Paradigm in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}